Ever wonder what kind of TV shows your dog might choose if they could work the r...
South Florida’s Nearshore Reefs Less Vulnerable to Ocean Acidification, Study Fi...
A Rutgers researcher, through his spinoff company, has led a team to design and ...
18 January 2024: Researchers in the School of Population Health at RCSI Universi...
Disco Pharmaceuticals has recently taken the pharmaceutical stage, bolstered by ...
The decision invalidates all claims of patent infringement, which has been centr...
AI in telemedicine for behavioural health can revolutionise patient access to tr...
Speaking at Davos, WHO chief Dr. Ghebreyesus said learning lessons from the Covi...
In a report, findings suggested that cancer patients in the Netherlands will fac...
The Switzerland based company plans to use the Series B money to fund clinical t...
KBI Biopharma and Argonaut have entered into a strategic partnership to provide ...
The US FDA has approved Vertex's CASGEVY, a gene-edited cell therapy, to treat t...
The EC has granted orphan drug designation (ODD) for Precigen's PRGN-2012 aimed ...
The British health insurance and coverage provider is well-placed to invest in n...
Coya plans to file investigational new drug applications for COYA 302 in amyotro...
Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biol...
